Efficacy of vaccines based on chimeric or multiepitope antigens for protection against visceral leishmaniasis: A systematic review.
<h4>Background</h4>Visceral leishmaniasis (VL) is an infectious parasitic disease caused by the species Leishmania (Leishmania) infantum in the Mediterranean Basin, the Middle East, Central Asia, South America, and Central America, and Leishmania (Leishmania) donovani in Asia and Africa....
Saved in:
| Main Authors: | Karine Ferreira Lopes, Mariana Lourenço Freire, Silvane Maria Fonseca Murta, Edward Oliveira |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2024-12-01
|
| Series: | PLoS Neglected Tropical Diseases |
| Online Access: | https://doi.org/10.1371/journal.pntd.0012757 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Design and development of highly conserved, HLA-promiscuous T cell multiepitope vaccines against human visceral leishmaniasis
by: Aline Silva Barreto, et al.
Published: (2025-03-01) -
Diagnosis of the Multiepitope Protein rMELEISH3 for Canine Visceral Leishmaniasis
by: Rita Alaide Leandro Rodrigues, et al.
Published: (2025-08-01) -
Cross-protection against homo and heterologous influenza viruses via intranasal administration of an HA chimeric multiepitope nanoparticle vaccine
by: Yongqiang Zhao, et al.
Published: (2025-02-01) -
Development of Vaccines against Visceral Leishmaniasis
by: Krystal J. Evans, et al.
Published: (2012-01-01) -
Immunoinformatic design of chimeric multiepitope vaccine for the prevention of human metapneumovirus (hMPV)
by: Maryam Ehsasatvatan, et al.
Published: (2025-07-01)